Research Article

Malignancy Risk Assessment in Patients with Thyroid Nodules Using Classification and Regression Trees

Table 1

Descriptive characteristics of 271 patients referred for thyroid nodule evaluation between 2006 and 2011.

BenignMalignantP valueTotal

Age (years)0.008
 <3037 (19.0)20 (26.3)57 (21.0)
 ≥30 and ≤60135 (69.2)38 (50.0)173 (63.8)
 >6023 (11.8)18 (23.7)41 (15.2)
Sex (women/men)167/2855/210.011222/49
Thyroid enlargement, (%)110 (56.4)46 (60.5)0.538156 (57.6)
Number of nodules, (%)0.191
 Single 182 (93.3)74 (97.4)256 (94.5)
 Multiple13 (6.7)2 (2.6)15 (5.5)
Nodule size, (%)<0.001
 <2 cm4 (2.1)10 (13.2)15 (5.5)
 2–5 cm128 (65.6)52 (68.4)179 (66.0)
 >5 cm 63 (32.3)14 (18.4)77 (28.5)
TFT, (%)0.288
 Hyperthyroid9 (4.6)2 (2.6)11 (4.1)
 Euthyroid139 (71.3)49 (64.5)188 (69.4)
 Hypothyroid47 (24.1)25 (32.9)72 (26.5)
FNA, results (%)<0.001
 Nondiagnostic16 (8.2)7 (9.2)23 (8.5)
 Benign44 (22.5)8 (10.5)52 (19.2)
 Indeterminate85 (43.6)8 (10.5)93 (34.3)
 Suspicious46 (23.6)12 (15.8)58 (21.4)
 Malignant4 (2.1)41 (54.0)45 (16.6)

Abbreviations: TFT: thyroid function test; FNA: fine needle aspiration.